Mounjaro vs Wegovy: Which Weight Loss Injection is Right for You?
Compare Mounjaro and Wegovy head-to-head: efficacy, side effects, cost, and availability in New Zealand to help you...

Compare Mounjaro and Wegovy head-to-head: efficacy, side effects, cost, and availability in New Zealand to help you...

If you're researching weight loss injections in New Zealand, you've likely come across both Mounjaro and Wegovy. Both are highly effective GLP-1 medications, but they work differently and produce different results. This guide compares the two medications head-to-head to help you understand which might be right for you.
The fundamental difference between these medications lies in their mechanism of action:
This dual-action approach is why Mounjaro consistently outperforms Wegovy in clinical trials. The GIP receptor appears to enhance the effects of GLP-1 activation, creating a synergistic effect on appetite, metabolism, and fat breakdown.
Clinical trials have directly compared these medications, and the results consistently favour Mounjaro:
In the SURMOUNT-5 head-to-head trial, participants on tirzepatide lost an average of 20.2% of their body weight compared to 13.7% for semaglutide over 72 weeks. That's approximately 6.5 percentage points more weight loss with Mounjaro.
Both medications are administered once weekly via subcutaneous injection using pre-filled pens. However, their dosing schedules differ:
Mounjaro has a longer titration period with more dose steps, which may help patients adjust more gradually to the medication.
Both medications share similar gastrointestinal side effects, which are the most common complaints:
Clinical trials show no significant difference in the rate or severity of side effects between the two medications. Both typically cause the most discomfort during dose escalation, with symptoms improving over time.
Both carry the same boxed warning regarding thyroid C-cell tumours and are contraindicated in people with a history of medullary thyroid carcinoma or MEN 2 syndrome.
Both medications are available in New Zealand:
Neither medication is funded by Pharmac for weight loss, so both are private-pay only.
Current and expected pricing in New Zealand:
Mounjaro's dose-dependent pricing means you'll pay less during the initial titration months. Starting doses (2.5mg at $430, 5mg at $500) are comparable to Wegovy. Higher maintenance doses (10mg at $690, 15mg at $875) cost more than Wegovy's flat rate.
Here's our practical guidance:
If you're currently on Wegovy and interested in potentially better results, switching to Mounjaro is now possible. Discuss the timing and transition plan with your prescriber.
At Well Revolution, we currently offer comprehensive medical support for Wegovy and Mounjaro treatment in New Zealand. Our chat-based GP service provides:
Start your weight loss journey today with either medication, or speak with our doctors about which option is right for you.
Concerned, need advice, a prescription, refill or referral?
Chat with a GP now